Related Experiment Video
Updated: Jun 14, 2026

Combined In vivo Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice
Published on: October 16, 2014
Extracellular matrix scaffold crosslinked with vancomycin for multifunctional antibacterial bone infection therapy
Bin Fang1, Pengcheng Qiu2, Chen Xia2
1Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, China; Department of Spine Surgery, The Central Hospital Affiliated to Shaoxing University, Shaoxing, China; Department of Spine Surgery, Shaoxing Central Hospital, China Medical University, Shaoxing, China; Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, China.
A novel vancomycin-crosslinked bone scaffold (Van-SDECM) effectively treats bone infections by releasing antibiotics and promoting bone healing. This multifunctional material inhibits biofilms and supports osteogenesis, offering a promising solution for chronic bone infections.
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Orthopedic Surgery
Background:
- Bone infections are challenging due to biofilms and dormant bacteria.
- Current treatments struggle with chronic infections and biofilm formation.
- Developing multifunctional materials is crucial for effective bone infection therapy.
Purpose of the Study:
- To synthesize and evaluate a novel vancomycin-crosslinked demineralized extracellular cancellous bone (SDECM) scaffold (Van-SDECM) for multifunctional bone infection therapy.
- To investigate the in vitro and in vivo anti-infective and osteogenic properties of Van-SDECM.
- To explore the mechanisms underlying the therapeutic effects of Van-SDECM.
Main Methods:
- Synthesis of Van-SDECM via electrostatic interactions and chemical bonds.
- In vitro assessment of pH-sensitive release, biofilm inhibition, and sustained bactericidal activity.
- In vivo evaluation using an infectious bone defect model in animals.
- Analysis of osteogenic performance, osteoclast activity, and immunoregulation.
Main Results:
- Van-SDECM demonstrated pH-sensitive vancomycin release and effective biofilm inhibition in vitro.
- The scaffold exhibited sustained bactericidal ability and favorable osteogenic performance.
- In vivo studies confirmed the comprehensive anti-infective and osteogenic capabilities of Van-SDECM.
- Mechanisms include pH-sensitive sterilization, scaffold contact killing, osteoclast inhibition, and osteogenesis promotion.
Conclusions:
- Van-SDECM is a promising multifunctional material for treating bone infections.
- The material effectively combats biofilms, promotes bone regeneration, and modulates the immune response.
- This study presents a novel drug-scaffold composite preparation method using native-derived extracellular matrix.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

